ليست عنوان مقالات لاتين Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control Dry etching of zinc-oxide and indium-zinc-oxide in IBr and BI3 plasma chemistries

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

2

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

3

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

4

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

5

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

6

Drosophila model increases understanding of fragile-X syndrome

7

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

8

Drosophila neural progenitor polarity and asymmetric division

9

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

10

Drosophila p53 Binds a Damage Response Element at the reaper Locus

11

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

12

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

13

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

14

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

15

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

16

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

17

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

18

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

19

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

20

Drosophila still flying high in cancer research

21

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

22

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

23

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

24

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

25

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

26

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

27

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

28

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

29

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

30

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

31

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

32

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

33

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

34

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

35

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

36

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

37

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

38

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

39

Drought and climatic change impact on streamflow in small watersheds Original Research Article

40

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

41

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

42

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

43

Drought and ecosystem carbon cycling

44

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

45

Drought and grazing patch dynamics under different grazing management

46

Drought and malaria retreat in the Sahel, West Africa

47

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

48

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

49

Drought and saving in West Africa: are livestock a buffer stock?

50

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

51

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

52

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

53

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

54

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

55

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

56

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

57

Drought disturbance from climate change: response of United States forests

58

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

59

Drought early warning system in reservoir operation: Theory and practice

60

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

61

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

62

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

63

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

64

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

65

Drought experiments within the Solling roof project

66

Drought Flow from Hillslope

67

Drought Flow from Hillslope

68

Drought forecasting based on the remote sensing data using ARIMA models

69

Drought forecasting using feed-forward recursive neural network

70

Drought forecasting using feed-forward recursive neural network

71

Drought forecasting using the Standardized Precipitation Index

72

Drought frequency analysis using cluster analysis and bivariate probability distribution

73

Drought identification and characterization in Jordan

74

Drought impacts on the water quality of freshwater systems; review and integration

75

Drought in groundwater—drought distribution and performance indicators

76

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

77

Drought is a major yield loss factor for rainfed East African highland banana

78

Drought mitigation using operative indicators in complex water systems

79

Drought modeling – A review

80

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

81

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

82

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

83

Drought monitoring in Iran using the perpendicular drought indices

84

Drought Monitoring in Southern Coasts of Iran

85

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

86

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

87

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

88

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

89

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

90

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

91

Drought planning and water allocation: an assessment of local capacity in Minnesota

92

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

93

Drought probabilities and return period for annual streamflows series

94

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

95

Drought response of two bedding plants

96

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

97

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

98

Drought Risk Assessment in Western Inner-Mongolia

99

Drought Risk Assessment: A Case Study in Punjab, Pakistan

100

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

101

Drought Risk Vulnerability Parameters among Wheat

102

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

103

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

104

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

105

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

106

Drought stress effect on some phonological traits of advanced lines of bread wheat

107

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

108

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

109

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

110

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

111

Drought stress tolerance based on selection indices of resistant crops variety

112

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

113

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

114

Drought Stress: A Review

115

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

116

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

117

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

118

Drought threatened semi-arid ecosystems in the Inner Asia

119

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

120

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

121

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

122

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

123

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

124

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

125

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

126

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

127

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

128

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

129

Drought variability and its climatic implications

130

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

131

Drought vulnerability assessment: The case of wheat farmers in Western Iran

132

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

133

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

134

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

135

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

136

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

137

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

138

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

139

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

140

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

141

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

142

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

143

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

144

Drought-induced variations of water relations parameters in Olea europaea

145

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

146

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

147

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

148

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

149

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

150

Droughts as random events in the Maya lowlands

151

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

152

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

153

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

154

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

155

Drowning by numbers and itʹs

156

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

157

Drowning in information, but thirsty for knowledge

158

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

159

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

160

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

161

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

162

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

163

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

164

Drowsiness Detection – A Visual System for Driver Support

165

Drs. Landon and Kahn respond:

166

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

167

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

168

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

169

Druen complement component C3a and C5a promote choroidal neovacularization

170

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

171

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

172

Drug abuse among nurses: A neglected challenge

173

Drug Abuse among University Students of Rafsanjan, Iran

174

Drug abuse and aggression between intimate partners: A meta-analytic review

175

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

176

Drug abuse in older US adults worries experts

177

Drug Abuse in Prishtina Region

178

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

179

Drug Abuse Research Trend Investigation with Text Mining

180

Drug abuse toll uncovered in Kenya

181

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

182

Drug abuse: A significant variable in schizophrenia research

183

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

184

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

185

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

186

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

187

Drug addiction and HIV infection on rise in Tajikistan

188

Drug addiction and the economic rationalization of gun control

189

Drug addiction and the economic rationalization of gun control

190

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

191

Drug addiction as drive satisfaction ("antidrive") dysfunction

192

Drug Addiction as Risk for Suicide Attempts

193

Drug addiction in Gaza and the illicit trafficking of tramadol

194

Drug addiction: the neurobiology of disrupted self-control

195

Drug administration to poultry

196

Drug adverse events and drop-out risk: A clinical case

197

Drug advertisements and prescribing

198

Drug advertisements and prescribing

199

Drug advertisements in less-developed countries

200

Drug advertisements in medical journals

201

Drug advertisements that go straight to the hippocampus

202

Drug advertising in medical journals

203

Drug advertising in medical journals

204

Drug advertising in medical journals

205

Drug advertising in medical journals

206

Drug advertising in medical journals

207

Drug advertising in medical journals

208

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

209

Drug allergic reactions and distress vulnerability

210

Drug allergies among patients with borderline personality symptomatology

211

212

Drug allergy transmitted by passionate kissing

213

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

214

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

215

Drug and alcohol use among drivers admitted to a Level-1 trauma center

216

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

217

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

218

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

219

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

220

Drug and DNA delivery to mitochondria

221

Drug and DNA delivery to mitochondria

222

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

223

Drug and gene delivery to mucosal tissues: the mucus barrier

224

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

225

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

226

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

227

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

228

Drug bulletins: independent information for global use

229

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

230

Drug calculation skills — Are we running scared?

231

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

232

Drug choices in the treatment of atrial fibrillation

233

Drug classification systems: Applications and characteristics

234

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

235

Drug combinations best in acute asthma attacks

236

Drug combinations for HD tested in Drosophila

237

Drug combinations for malaria: time to ACT?

238

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

239

Drug companies can broadcast across Europe

240

Drug companies caught again for fixing worldwide vitamin prices

241

Drug company sued over research trial in Nigeria

242

Drug company trials come under increasing scrutiny

243

Drug comparison and categorizing regarded with human serum albumin

244

Drug complications poorly recorded in medical charts

245

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

246

Drug courts: A bridge between criminal justice and health services

247

Drug Craving Terminology among Opiate Dependents;

248

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

249

Drug crops threaten Colombian birds

250

251

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

252

Drug delivery applications of supercritical fluid technology

253

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

254

Drug delivery devices based on macroporous silica spheres

255

Drug Delivery for Brains and Central Nervous System

256

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

257

Drug delivery from gold and titanium surfaces using self-assembled monolayers

258

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

259

Drug delivery in degenerative joint disease

260

Drug delivery in degenerative joint disease: Where we are and where to go?

261

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

262

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

263

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

264

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

265

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

266

Drug delivery strategies in the therapy of inflammatory bowel disease

267

Drug delivery strategies to treat age-related macular degeneration

268

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

269

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

270

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

271

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

272

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

273

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

274

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

275

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

276

Drug delivery to mitochondria: the key to mitochondrial medicine

277

Drug delivery to mitochondria: the key to mitochondrial medicine

278

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

279

Drug delivery to solid tumors by elastin-like polypeptides

280

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

281

Drug delivery to the brain-just a sniff away

282

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

283

Drug delivery to the posterior segments of the eye

284

Drug delivery vehicles on a nano-engineering perspective

285

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

286

Drug Dependency and Womenʹs Health

287

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

288

Drug deregulation in Japan likely by 1998

289

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

290

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

291

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

292

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

293

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

294

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

295

Drug detection by tandem mass spectrometry on the basis of adduct formation

296

Drug development and clinical research in the UK

297

Drug development for neglected diseases

298

Drug development for neglected diseases: a deficient market and a public-health policy failure

299

Drug development for tuberculosis: the missing ingredient

300

Drug development output: what proportion for tropical diseases?

301

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

302

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

303

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

304

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

305

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

306

Drug discovery and chemokine receptor antagonists: eppur si muove!

307

Drug Discovery and Delivery in the 21st Century

308

Drug Discovery and Evaluation

309

Drug discovery and sea hares: bigger is better

310

Drug Discovery in the Clouds

311

Drug discovery in the new millennium: the pivotal role of biotechnology

312

Drug discovery in the wake of genomics

313

Drug discovery of the future: the implications of the human genome project

314

Drug discovery through stem cell-based organoid models

315

Drug dispensing systems in Gaza hospitals: a comparative study

316

Drug disposition in obesity and protein-energy malnutrition

317

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

318

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

319

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

320

Drug efflux transporters in the CNS

321

Drug elimination in chronic liver diseases

322

Drug eluting stent

323

Drug ELuting Stent Complications

324

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

325

Drug Eluting Stent Restenosis

326

Drug eluting stents

327

Drug Eluting Stents Comparisons

328

Drug Eluting Stents I

329

Drug Eluting Stents II

330

Drug Eluting Stents in Diabetic Patients

331

Drug eluting stents may not be the answer for myocardial bridges

332

Drug eluting stents: Comparative results

333

Drug eluting stents: Current status and new developments

334

Drug eluting stents: In stent restenosis

335

Drug eluting stents: Long term results

336

Drug eradicates Chagasʹ parasite in mice

337

Drug evaluations using a novel microphysiometer based on cell-based biosensors

338

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

339

Drug excretion into breast milk—Overview

340

Drug exposed infants in the social welfare system and Juvenile Court

341

Drug firm buys up chain of US cancer clinics

342

Drug firm compensates patients for suspected hepatitis B vaccine failure

343

Drug firm support of American Medical Association ethics effort draws fire

344

Drug firm withdraws statin from the market

345

Drug firms lose patent rights lawsuit against South Africaʹs government

346

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

347

Drug firms take South Africaʹs government to court

348

Drug firms under fire over anti-competition in USA

349

Drug for impotence breaks prescription records

350

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

351

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

352

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

353

Drug identification performance on the basis of observable signs and symptoms

354

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

355

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

356

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

357

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

358

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

359

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

360

Drug Induced Ectropion: a Systematic Review

361

Drug Induced Gingival Overgrowth and Its Management

362

Drug induced hepatitis among Iranian patients suffering from tuberculosis

363

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

364

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

365

Drug industry lobbies against European research-data directive

366

Drug Information Resources at Private Community Pharmacies in Kuwait

367

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

368

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

369

Drug injection cessation among HIV-infected injecting drug users

370

Drug interaction between rifampicin and sirolimus in transplant patients

371

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

372

Drug interaction of St Johnʹs wort with ciclosporin

373

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

374

Drug interactions and anti-infective therapies

375

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

376

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

377

Drug interactions in cancer patients: A hidden risk?

378

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

379

Drug Interactions of Green Tea

380

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

381

Drug Interactions of Metformin Involving Drug Transporter Proteins

382

Drug Interactions of Psychiatric and COVID-19 Medications

383

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

384

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

385

Drug interactions with the taxanes: clinical implications

386

Drug interactions with zileuton

387

Drug interactions with zileuton

388

Drug interactions—fact or fiction?

389

Drug intervention trials in sepsis

390

Drug intervention trials in sepsis: divergent results

391

Drug kinetics and drug resistance in optimal chemotherapy

392

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

393

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

394

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

395

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

396

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

397

Drug Management in Crisis and Disaster in Selected Countries and Iran

398

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

399

Drug may avoid need for parathyroidectomy

400

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

401

Drug metabolism and drug interactions in the elderly

402

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

403

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

404

Drug nanocarrier agents based on starch-g-amino acids

405

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

406

Drug partition chromatography on immobilized porcine intestinal brush border membranes

407

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

408

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

409

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

410

Drug policy in China: pharmaceutical distribution in rural areas

411

Drug policy: should the law take a back seat?

412

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

413

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

414

Drug Prescription Pattern in a Nigerian Tertiary Hospital

415

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

416

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

417

Drug prevents SIV infection

418

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

419

Drug problem recognition among african american drug-using arrestees

420

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

421

Drug quality, a contributor to drug resistance?

422

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

423

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

424

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

425

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

426

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

427

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

428

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

429

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

430

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

431

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

432

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

433

Drug referendum backs Swiss government

434

Drug reimportation: sitting in the middle

435

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

436

Drug related deaths—causes and numbers

437

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

438

Drug release behavior of beads and microgranules of chitosan

439

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

440

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

441

Drug release characteristics of phase separation pHEMA sponge materials

442

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

443

Drug release from a porous ion-exchange membrane in vitro

444

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

445

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

446

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

447

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

448

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

449

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

450

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

451

Drug release kinetics and biological properties of a novel local drugcarrier system

452

Drug release kinetics from monolayer films of glucose-sensitive microgel

453

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

454

Drug release rate and kinetic investigation of composite polymeric nanofibers

455

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

456

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

457

Drug release through liposome pores

458

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

459

Drug Repositioning: A Review

460

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

461

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

462

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

463

Drug resistance among acid-fast bacilli

464

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

465

Drug resistance and apoptosis-inducing strategies in cancer therapy

466

Drug resistance and influenza pandemics

467

Drug resistance and influenza pandemics

468

Drug resistance and influenza pandemics

469

Drug resistance and influenza pandemics

470

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

471

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

472

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

473

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

474

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

475

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

476

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

477

Drug resistance in epilepsy: not futile, but complex?

478

Drug Resistance in Equine Parasites: An Emerging Global Problem

479

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

480

Drug resistance in malaria: Its population biology and implications for control

481

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

482

Drug resistance in tuberculosis—a reinfection model

483

Drug resistance models for malaria

484

Drug Resistance of Acinetobacter in Selected Hospitals

485

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

486

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

487

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

488

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

489

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

490

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

491

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

492

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

493

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

494

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

495

Drug resistance patterns in pulmonary tuberculosis

496

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

497

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

498

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

499

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

500

Drug Resistance: A Periplasmic Ménage à Trois

501

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

502

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

503

Drug resistant Plasmodium falciparum in an area of seasonal transmission

504

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

505

Drug Resistant Tuberculosis: Gold, Glitter and Hope

506

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

507

Drug Safety Crises Management in Pharmacovigilance

508

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

509

510

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

511

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

512

Drug shows potential for treatment of Huntingtonʹs disease

513

Drug shows promise for treatment of Alzheimerʹs disease

514

Drug solubility: how to measure it, how to improve it

515

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

516

Drug subsidy could help Tanzania tackle malaria

517

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

518

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

519

Drug Switching, a Creative Approach to Leukemia Therapy

520

Drug target inference through pathway analysis of genomics data

521

Drug targeting of airway surface liquid: A pharmacological MRI approach

522

Drug targeting to choroidal neovascularization

523

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

524

Drug targeting to the kidney

525

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

526

Drug testing litigation: Trends and outcomes

527

Drug testing sworn law enforcement officers: One agencyʹs experience

528

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

529

530

531

Drug therapy and microvolt T-wave alternans testing

532

Drug therapy and microvolt T-wave alternans testing

533

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

534

Drug therapy for coronary heart disease: the Sheffield table

535

Drug therapy for coronary heart disease: the Sheffield table

536

Drug therapy for coronary heart disease: the Sheffield table

537

Drug therapy for coronary heart disease: the Sheffield table

538

Drug therapy for coronary heart disease: the Sheffield table

539

Drug therapy for coronary heart disease: the Sheffield table

540

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

541

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

542

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

543

Drug therapy for management of obesity

544

Drug therapy for management of obesity

545

Drug Therapy for Small Abdominal Aortic Aneurysm

546

Drug therapy for treatment of obesity

547

Drug therapy for urinary incontinence

548

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

549

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

550

Drug therapy in paediatric patients

551

Drug therapy in reproductive endocrinology

552

Drug therapy increases long-term survival in pulmonary hypertension patients

553

Drug therapy of diabetes in the elderly

554

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

555

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

556

Drug Trafficking and Criminal Justice

557

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

558

Drug transfer through mucus

559

Drug transfer through mucus

560

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

561

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

562

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

563

Drug transport proteins in the liver

564

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

565

Drug treatment for bleeding oesophageal varices

566

Drug treatment for Crohnʹs disease

567

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

568

Drug treatment of delirium: Past, present and future

569

Drug treatment of non-variceal upper gastrointestinal bleeding

570

Drug treatment of obesity

571

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

572

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

573

Drug treatment-related factors of inadequate seizure control

574

Drug treatments for obesity

575

Drug treatments for obesity

576

Drug treatments for obesity

577

Drug treatments for obesity – Authorsʹ reply

578

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

579

Drug treatments of levodopa-induced dyskinesias

580

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

581

Drug use and abuse in sport

582

Drug use and drinking among students in 36 countries

583

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

584

Drug use and HIV/ AIDS in Burma

585

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

586

Drug use and the severity of a traffic accident

587

Drug use behaviors among asian drug users in san francisco

588

Drug use behaviour of pregnant women in rural India

589

Drug use during pregnancy

590

Drug use during pregnancy

591

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

592

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

593

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

594

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

595

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

596

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

597

Drug use is associated with elevated food consumption in college students

598

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

599

Drug Use Patterns at Major Rock Concert Events

600

Drug usersʹ access to community-based services

601

Drug usersʹ brains to be removed 2 hours after death

602

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

603

Drug utilisation and self-medication in rural communities in Vietnam

604

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

605

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

606

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

607

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

608

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

609

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

610

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

611

Drug Utilization Evaluation of Colistin: A Retrospective Study

612

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

613

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

614

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

615

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

616

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

617

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

618

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

619

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

620

Drug Utilization Evaluation of Vancomycin in Pediatric Department

621

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

622

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

623

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

624

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

625

Drug with potential to clear amyloid

626

Drug/device combinations for local drug therapies and infection prophylaxis

627

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

628

Drug-company sponsorship and the Declaration of Helsinki

629

Drug-company sponsorship and the Declaration of Helsinki

630

Drug-delivering coronary artery stents: bare metal threatened by extinction?

631

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

632

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

633

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

634

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

635

Drug-drug co-crystals

636

Drug-Drug Interaction Extraction via Convolutional Neural Networks

637

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

638

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

639

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

640

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

641

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

642

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

643

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

644

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

645

Drug-Drug-Induced Akathisia: Two Case Reports

646

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

647

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

648

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

649

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

650

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

651

Drug-eluting bioabsorbable stents – An in vitro study

652

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

653

Drug-eluting stent fracture occurred within 2 days after stent implantation

654

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

655

Drug-Eluting Stent Fracture: Promise and Performance

656

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

657

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

658

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

659

Drug-Eluting Stent Thrombosis: A Pooled Analysis

660

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

661

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

662

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

663

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

664

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

665

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

666

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

667

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

668

Drug-Eluting stents

669

Drug-Eluting Stents “Next Generation” Basic Science Workshop

670

Drug-eluting stents 1— preclinical

671

Drug-eluting stents 2-economics and cost effectiveness

672

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

673

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

674

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

675

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

676

Drug-eluting stents and late stent thrombosis

677

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

678

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

679

Drug-Eluting Stents for Acute Myocardial Infarction

680

Drug-eluting stents for coronary artery disease: A review

681

Drug-Eluting Stents for Critical Limb Ischemia

682

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

683

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

684

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

685

Drug-eluting stents in diabetics & Complex patient groups

686

Drug-Eluting Stents in Heart Transplant Recipients

687

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

688

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

689

Drug-eluting stents in vascular intervention

690

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

691

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

692

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

693

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

694

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

695

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

696

Drug-eluting stents: A multidisciplinary success story

697

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

698

Drug-eluting stents: Beyond the hyperbole

699

Drug-eluting stents: Factors governing local pharmacokinetics

700

Drug-eluting stents: Failures and restenosis

701

Drug-eluting stents: insights into safety and indications

702

Drug-eluting stents: is new necessarily better?

703

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

704

Drug-eluting stents: Lesion subsets

705

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

706

Drug-eluting stents: Miscellaneous

707

Drug-eluting stents: Patient and lesion subsets

708

Drug-eluting stents: Registries and trials

709

Drug-eluting stents: Registries and trials

710

Drug-eluting stents: results, promises and problems

711

Drug-eluting stents: some bare facts

712

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

713

Drug-evaluation harmonisation will lead to fewer animal tests

714

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

715

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

716

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

717

Drugging Drug Resistance

718

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

719

Drugging the Undruggable

720

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

721

Drug-hormone interactions on neurobehavioral responses in human neonates

722

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

723

Drug-induced amnesia impairs implicit relational memory

724

Drug-induced and toxic myopathies

725

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

726

Drug-induced atrial fibrillation Review Article

727

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

728

Drug-induced autoimmunity

729

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

730

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

731

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

732

Drug-induced cholestasis

733

Drug-induced gingival overgrowth and its tentative pharmacotherapy

734

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

735

Drug-induced headaches

736

Drug-induced headaches

737

Drug-induced heart failure

738

drug-induced hemophagocytosis

739

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

740

Drug-induced hyperkalemia

741

Drug-induced hyperkalemia: old culprits and new offenders

742

Drug-induced hyperkalemia: The reply:

743

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

744

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

745

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

746

Drug-Induced Lichen Planus

747

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

748

Drug-induced liver diseases

749

Drug-induced liver injury following positive drug rechallenge

750

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

751

Drug-Induced Lupus Erythematosus

752

Drug-induced lupus erythematosus

753

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

754

Drug-induced myocardial infarction in young patients: Report of two cases

755

Drug-induced Nephrotoxicity and Medicinal Plants

756

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

757

Drug-Induced Pemphigoid:: Bullous and Cicatricial

758

Drug-Induced Pemphigus

759

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

760

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

761

Drug-induced renal disorders

762

Drug-Induced Scleroderma and Sclerodermiform Conditions

763

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

764

Drug-induced systemic lupus erythematosus and TNF-α blockers

765

Drug-induced systemic lupus erythematosus and TNF-α blockers

766

Drug-induced systemic lupus erythematosus and TNF-α blockers

767

Drug-induced systemic lupus erythematosus associated with etanercept therapy

768

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

769

Drug-Induced Toxic Epidermal Necrolysis

770

Drug-induced tremors

771

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

772

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

773

Drug-licensing anomalies and Parkinsonʹs disease

774

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

775

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

776

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

777

Drug-lunch alert

778

Drugmaker seeks permissions to collaborate on Cuban vaccine

779

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

780

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

781

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

782

Drug-related killings: a case of mistaken identity Review Article

783

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

784

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

785

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

786

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

787

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

788

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

789

Drug-resistant enteric fever in the UK

790

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

791

Drug-resistant genotyping in HIV-1 therapy

792

Drug-resistant genotyping in HIV-1 therapy

793

Drug-resistant genotyping in HIV-1 therapy

794

Drug-resistant genotyping in HIV-1 therapy

795

Drug-resistant genotyping in HIV-1 therapy

796

Drug-resistant gonorrhoeae spread in the USA

797

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

798

Drug-resistant Pneumocystis carinii

799

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

800

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

801

Drug-resistant strains of HIV increase sharply in Japan

802

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

803

Drug-resistant tuberculosis

804

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

805

Drug-resistant tuberculosis in Taipei, 1996-1999

806

Drug-resistant tuberculosis: desperate measures?

807

Drugs & devices in brief

808

Drugs against superbugs: private lessons from bacteriophages

809

Drugs and a dark future

810

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

811

Drugs and demons

812

Drugs and mental health

813

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

814

Drugs and nutrition: how side effects can influence nutritional intake

815

Drugs and nutrition: Important drug-nutrient interactions

816

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

817

Drugs and pests: intertemporal production externalities

818

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

819

Drugs and risk-taking in tourism

820

Drugs and the art of Fred Tomaselli

821

Drugs and the immune system: the emerging era of immunopharmacology

822

Drugs deaths drop in Switzerland

823

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

824

Drugs Expiration Date Dilemma!

825

Drugs for Left Ventricular Remodeling in Heart Failure

826

Drugs for obstetric conditions

827

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

828

Drugs for vascular dementia

829

Drugs in Exacerbation and Provocation of Psoriasis

830

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

831

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

832

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

833

Drugs in the Plant

834

Drugs in the postgenomic era

835

Drugs Induced Alzheimer’s Disease in Animal Model

836

Drugs lose out to revascularisation in symptom-free coronary disease

837

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

838

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

839

Drugs of Abuse and Immuno-Modulation

840

Drugs of abuse and reward comparison: a brief review

841

Drugs of abuse and the elicitation of human aggressive behavior

842

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

843

Drugs of abuse in pregnancy

844

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

845

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

846

Drugs Prescribed by Dentists in Fars Province, Iran

847

Drugs solubilization in ascorbyl–decanoate micellar solutions

848

849

Drugs Used in Pregnancy

850

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

851

Drugs, diet and disease

852

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

853

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

854

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

855

Drug-testing practices in US hotels

856

Drug-trial “irregularities” uncovered in Argentina

857

Drug-trial compensation demands in lreland

858

Drug-use behavior and correlates in people with schizophrenia

859

Drug-use initiation and conduct disorder among adolescents in drug treatment

860

Druid wins Baan contract with Weston Aerospace

861

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

862

Drum granulation of NPK fertilizers

863

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

864

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

865

Drum-boiler dynamics

866

Drum-like silencers using magnetic forces in a pressurized cavity

867

868

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

869

Drunk driving and mental disorders

870

Drunk driving and mental disorders

871

Drunk, but not blind: The effects of alcohol intoxication on change blindness

872

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

873

Drushbametrics — My Russian adventures

874

Dry aging of beef in a bag highly permeable to water vapour

875

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

876

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

877

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

878

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

879

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

880

Dry and wet abrasive resistance of Inconel 600 and stellite

881

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

882

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

883

Dry and wet deposition of elements in Hong Kong

884

Dry and wet deposition of mercury near a chlor-alkali plant

885

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

886

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

887

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

888

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

889

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

890

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

891

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

892

Dry atmospheric deposition and diazotrophy as sources of new nitrogen to northwestern Mediterranean oligotrophic surface waters

893

Dry atmospheric deposition rates of metals along a coastal transect in southern California

894

Dry atmospheric fluxes of trace metals (Al, Fe, Mn, Pb, Cd, Zn, Cu) over the Levantine Basin: A refined assessment

895

Dry atmospheric inputs of trace metals at the Mediterranean coast of Israel (SE Mediterranean): sources and fluxes

896

Dry bag isostatic pressing for improved green strength of surrogate nuclear fuel pellets

897

Dry Bean Intake of Women Ages 19-45

898

Dry Bean Production in Zero and Conventional Tillage

899

Dry beneficiation of Slovakian coal

900

Dry beneficiation technology of coal with an air dense-medium fluidized bed

901

Dry boards as load bearing element in the profiled steel sheet dry board floor panel system—structural performance and applications

902

Dry catalyst impregnation in a double cone blender: A computational and experimental analysis

903

Dry catalytic partial oxidation of diesel–fuel distillates into syngas

904

Dry citrate-precursor synthesized nanocrystalline cobalt oxide as highly active catalyst for total oxidation of propane

905

Dry cleaning for metallic contaminants removal as the second cleaning process after the CMP process

906

Dry cleaning of metal surfaces by a vacuum arc

907

Dry climate near the Western Pacific Warm Pool: Pleistocene caliches of the Nansha Islands, South China Sea

908

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

909

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

910

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

911

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

912

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

913

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

914

Dry coating of talc particles with fumed silica: Influence of the silica concentration on the wettability and dispersibility of the composite particles

915

Dry coating polymer powder particles with deagglomerated carbon nanotubes to improve their dispersion in nanocomposites

916

Dry coatings and ecodesign part. 1 — Environmental performances and chemical properties

917

Dry coatings and ecodesign: Part. 2 — Tribological performances

918

Dry cooling towers as condensers for geothermal power plants

919

Dry cooling with night cool storage to enhance solar power plants performance in extreme conditions areas

920

Dry cupping therapy and the wellness management of health travelers

921

Dry cutting performance of partially filtered arc deposited titanium aluminium nitride coatings with various metal nitride base coatings

922

Dry deep drawability of A5052 aluminum alloy sheet with DLC-coating

923

Dry degumming of vegetable oils by membrane filtration Original Research Article

924

Dry dense medium separation of iron ore using a gas–solid fluidized bed

925

Dry densification of carbon nanotube bundles Original Research Article

926

Dry deposition (downward, upward) concentration study of particulates and heavy metals during daytime, nighttime period at the traffic sampling site of Sha-Lu, Taiwan

927

Dry deposition and concentration of marine aerosols in a coastal area, SW Sweden

928

Dry deposition and foliar leaching of mercury and selected trace elements in deciduous forest throughfall

929

Dry deposition and interception of 4–22 μm diameter particles to a lettuce crop

930

Dry deposition and internal circulation of nitrogen, sulphur and base cations to a coniferous forest

931

Dry deposition and particle-size distribution of phosphorus in the marine atmosphere over the northeastern coast of Taiwan

932

Dry deposition and particle-size distributions of polycyclic aromatic hydrocarbons in the ambient air of a petrochemical plant

933

Dry deposition and resuspension of particle-associated metals near a freeway in Los Angeles

934

Dry deposition and soil–air gas exchange of polychlorinated biphenyls (PCBs) in an industrial area

935

Dry deposition calculations for the clean air status and trends network

936

Dry deposition effect of marine aerosol to the building stone of the medieval city of Rhodes, Greece

937

Dry deposition fluxes and atmospheric size distributions of mass, al, and mg measured in southern Lake Michigan during aeolos

938

Dry deposition fluxes and deposition velocities of PAHs at an urban site in Turkey

939

Dry deposition fluxes and velocities of polychlorinated biphenyls (PCBs) associated with particles

940

Dry deposition fluxes of ambient particulate heavy metals in a small city, Korea

941

Dry deposition measured with a water surface sampler: a comparison to modeled results

942

Dry deposition model for atmospheric particles

943

Dry deposition modelling of atmospheric aerosols from a lead smelting industry

944

Dry deposition of 214Pb to conifers

945

Dry deposition of acidic air pollutants to tree leaves, determined by a modified leaf-washing technique

946

Dry deposition of aerosol particles within model spruce canopies

947

Dry deposition of ammonia, nitric acid, ammonium, and nitrate to alpine tundra at Niwot Ridge, Colorado

948

Dry deposition of atmospheric polycyclic aromatic hydrocarbons (PAHs) in the southeast suburb of Beijing, China

949

Dry deposition of electrically charged aerosols

950

Dry deposition of gaseous elemental mercury to plants and soils using mercury stable isotopes in a controlled environment

951

Dry deposition of gaseous oxidized mercury in Western Maryland Original Research Article

952

Dry deposition of gaseous radioiodine and particulate radiocaesium onto leafy vegetables Original Research Article

953

Dry deposition of large, airborne particles onto a surrogate surface

954

Dry Deposition of Nonspherical Particles on Natural and Surrogate Surfaces

955

Dry deposition of ozone on building materials. Chamber measurements and modelling of the time-dependent deposition

956

Dry deposition of particles and canopy exchange: Comparison of wet, bulk and throughfall deposition at five forest sites in Italy

957

Dry deposition of particles in a coastal forest

958

Dry deposition of particles to building surfaces and soiling

959

Dry deposition of particles to wave surfaces: I. Mathematical modeling

960

Dry deposition of particles to wave surfaces: II. Wind tunnel experiments

961

Dry deposition of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) in ambient air

962

Dry deposition of polycyclic aromatic hydrocarbons in urban and rural sites of Western Greece

963

Dry deposition of reactive nitrogen to marine environments: recent advances and remaining uncertainties

964

Dry Deposition of SO2 Over Dry Dipterocarp Forest, Thailand

965

Dry deposition of sulfate-containing particulate at the highway intersection, coastal and suburban areas

966

Dry deposition of sulphate and nitrate to polypropylene surfaces in a semi-arid area of India

967

Dry deposition of sulphur dioxide and ammonia on wet surfaces and the surface oxidation kinetics of bisulphite

968

Dry deposition of sulphur over eastern South Africa

969

Dry deposition profile of small particles within a model spruce canopy

970

Dry deposition to forests—On the use of data from clearings

971

Dry deposition to pine of sulphur dioxide and ozone at low concentration

972

Dry deposition velocity of PM2.5 ammonium sulfate particles to a Norway spruce forest on the basis of S- and N-balance estimations

973

Dry deposition velocity of sulfur dioxide over rice paddy in the tropical region

974

Dry deposition washoff and dew on the surfaces of pine foliage on the urban- and mountain-facing sides of Mt. Gokurakuji, western Japan

975

Dry deposition, concentration and gas/particle partitioning of atmospheric carbazole

976

Dry deposition, ionic species measured and source interpretation during seasonal cycle at offshore areas near Taiwan Strait

977

Dry deposition, seasonal variation and source interpretation of ionic species at Abali, Firouzkouh and Varamin, Tehran Province, Iran

978

Dry dilute acid pretreatment by co-currently feeding of corn stover feedstock and dilute acid solution without impregnation

979

Dry dispersion of fine particles in gaseous phase

980

Dry dispersion of plant pulp in concrete and use thereof

981

Dry drainage: A sustainable solution to waterlogging and salinity problems in irrigation areas?

982

Dry elasto-plastic contact of nominally flat surfaces

983

Dry electrical discharge machining of cemented carbide

984

Dry etch characteristics of Al-Nd films for TFT-LCD

985

Dry etch chemistries for TiO2 thin films

986

Dry etching and implantation characteristics of III-N alloys

987

Dry etching and implantation characteristics of III-N alloys

988

Dry etching characteristics and surface reconstruction of Cl/Si(1 1 3)

989

Dry etching characteristics of (Ba0.6,Sr0.4)TiO3 thin films in high density CF4/Ar plasma

990

Dry etching characteristics of GaN for blue/green light-emitting diode fabrication

991

Dry etching characteristics of GaN using Cl2/BCl3 inductively coupled plasmas

992

Dry etching mechanism of copper and magnetic materials with UV illumination

993

Dry etching of AlTiC with CF/sub 4/ and H/sub 2/ for slider fabrication

994

Dry etching of bulk single-crystal ZnO in CH4/H2-based plasma chemistries

995

Dry etching of CuCrO2 thin films

996

Dry etching of ITO by magnetic pole enhanced inductively coupled plasma for display and biosensing devices

997

Dry etching of MgCaO gate dielectric and passivation layers on GaN

998

Dry etching of sapphire substrate for device separation in chlorine-based inductively coupled plasmas

999

Dry etching of surface textured zinc oxide using a remote argon–hydrogen plasma

1000

Dry etching of zinc-oxide and indium-zinc-oxide in IBr and BI3 plasma chemistries

بازگشت